ARTICLE | Clinical News
MoliChem starts CF Phase II
May 29, 2002 7:00 AM UTC
MLCM began a U.S. Phase II trial of Moli1901 to treat cystic fibrosis (CF). The compound is a polycyclic peptide antibiotic delivered through the lungs and induces chloride and water transport in airw...